Intermediate-risk pulmonary embolism: Aiming to improve patient stratification

Area of Science:

• Cardiology
• Pulmonary Medicine
• Medical Diagnostics

Background:

• Intermediate-risk pulmonary embolism (PE) poses a therapeutic challenge due to variable patient outcomes.
• Identifying patients at risk for adverse events and escalation of therapy is critical.

Purpose of the Study:

• To define predictors of clinical deterioration in intermediate-risk PE patients.
• To develop a risk stratification score for identifying patients who will not require escalation therapy.

Main Methods:

• Evaluation of 179 consecutive intermediate-risk PE patients.
• Allocation into groups requiring and not requiring escalation therapy.
• Formulation of a predictive score based on clinical, imaging, and laboratory parameters.

Main Results:

• 15% of patients required escalation therapy.
• Independent predictors for escalation included syncope and severe right ventricular (RV) dysfunction.
• A risk score demonstrated a strong correlation between score and risk for escalation therapy (1.9% to 57%).

Conclusions:

• A significant minority of intermediate-risk PE patients necessitate escalation of therapy.
• A combined score incorporating clinical, imaging, and laboratory data aids in risk stratification.
• This score can help identify intermediate-risk PE patients with a more favorable clinical course.